LYCOS RETRIEVER 
Genesis: Companies
built 291 days ago
Because Genesis improves companies' ability to analyse their own data (which has already been collected anyway), better and quicker decisions can ensue as soon as the situation changes. This can leverage performance with existing data, which Genesis can organize and quality-control through its unique quality-assurance process.
Source:
A near-production rear-drive large sedan concept, the Genesis looks to extend the brand’s upward trajectory to an even higher pricepoint. Powered by the company’s new Tau 4.6-liter DOHC 32-valve V-8, the company promises that when a production version of the Genesis hits in 2008, it will start at “well under $30,000.”
Source:
New York City time on January 23, 2008, the Company had received tenders of approximately 1.7 million shares of Genesis Microchip Inc. (Nasdaq: GNSS) during STMicroelectronics' previously announced subsequent offering period for Genesis. Together with shares tendered during the initial offer period, STMicroelectronics, through its wholly owned subsidiary, Sophia Acquisition Corp., has now accepted for payment approximately 34.0 million Genesis shares, representing approximately 88.8% of the outstanding Genesis shares.
Source:
Since its foundation in 1997, GENESIS Pharma -- one of the fastest growing Greek pharmaceutical companies -- has established itself as the premier marketer and distributor of biopharmaceutical products in Southeastern Europe. With its core business activity focusing on in-licensing, marketing, sales, and distribution of specialized pharmaceutical products stemming from biotechnology research, GENESIS Pharma has forged powerful strategic alliances through exclusive agreements with leading American and European companies of cellular and molecular technology, such as Amgen, Biogen Idec, Chiron, Cephalon, Shire and Vifor. The company has introduced and marketed an impressive portfolio of products in the region covering the fields of the Central Nervous System (CNS), Hematology / Oncology, Nephrology and Genetic disorders. Some products introduced by GENESIS Pharma include Aranesp, Avonex, Granulokine, Kineret, Modiodal, Neulasta, Tobi and Venofer.
Source:
At the same time, the company has unveiled the Genesis emblem consisting of the Genesis logotype set in a black hexagonal shield framed by a pair of wings. The wings, executed in a hyper-metallic silver, symbolize the spirt of flight and soaring above it all. However, the Genesis emblem will only be applied to the Korean and Chinese markets.
Source:
MORE ABOUT
Companies